Market Overview:
The global drugs for mouth ulcer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of mouth ulcers, rising awareness about oral health, and growing demand for over-the-counter (OTC) drugs. The global drugs for mouth ulcer market is segmented on the basis of type into antihistamine, antibacterial, corticosteroid and analgesic, and other types. The antibacterial type segment is expected to grow at the highest CAGR during the forecast period owing to increasing incidence of bacterial infections leading to mouth ulcers. On the basis of application, the global drugs for mouth ulcer market is segmented into hospitals, clinics, and other applications. The hospitals segment is expected to grow at a higher CAGR than other segments during the forecast period owing to rising number of hospital admissions due to oral health problems such as mouth ulcers.
Product Definition:
Mouth ulcers are a common problem that many people experience. They are small, open sores that can develop on the inside of the cheek, on the lips, or on the roof of the mouth. While there are many home remedies for mouth ulcers, such as salt water rinses or sucking on ice chips, sometimes medication is needed to help them heal.
-Analgesics such as ibuprofen or acetaminophen can help relieve pain and inflammation.
-Antibiotics may be prescribed if there is an underlying infection present.
-Hormone therapy may be recommended for women who experience frequent mouth ulcers related to their menstrual cycle.
Antihistamine:
Antihistamine is a drug that reduces the itching and scratching impulse. It works by blocking histamine, a chemical messenger that stimulates the nerve cells in the skin and produces itchy sensations. Some antihistamines also reduce swelling of blood vessels near itching areas.
The global market for antihistamines was valued at over USD 6 billion in 2013.
Antibacterial:
Antibacterial is a drug used for the treatment of mouth ulcers caused by Streptococcus mutans, group A beta-hemolytic streptococci, and other bacteria. It works by killing the bacteria that causes ulcers.
Application Insights:
Based on the application, the global drugs for mouth ulcer market is segmented into hospitals, clinics and other. Hospitals held the largest share of more than 60% in 2017 owing to availability of advanced healthcare facilities at a large scale across various regions. Moreover, hospitals are considered as one of the major sources for diagnosis as well as treatment due to wide range of medical expertise and equipment available in these settings.
Clinics are anticipated to be fastest growing segment over forecast period owing to increasing awareness about early diagnosis coupled with easy access to treatments through this channel. Furthermore, reduction in travel time involved with consultation at a clinic compared with that required when visiting a hospital is expected to have an impact on growth positively over forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of oral diseases and rising awareness about early diagnosis. Moreover, high healthcare expenditure and availability of advanced treatment options are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions, growing medical tourism industry, increase in disposable income levels, and rise in consumer awareness regarding available treatments for mouth ulcers. In addition, favorable government initiatives such as “Hospital E-Systems†implemented by Indian Ministry of Health & Family Welfare are also expected to contribute towards regional market growth during the forecast period.
Growth Factors:
- Increasing prevalence of mouth ulcers
- Rising awareness about the available treatments for mouth ulcers
- Growing demand for over-the-counter drugs for the treatment of mouth ulcers
- Increasing number of research and development activities focused on the development of new drugs for the treatment of mouth ulcers
- Technological advancements in drug delivery systems that can help improve the efficacy and tolerability profile of drugs for treating mouth ulcers
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Mouth Ulcer Market Research Report
By Type
Antihistamine, Antibacterial, Corticosteroid and Analgesic, Other
By Application
Hospitals, Clinics, Other
By Companies
Blistex, Church & Dwight, Novartis Pharmaceuticals, Bausch Health, Pfizer, M, Colgate-Palmolive, Sinclair Pharma, Blairex Laboratories, Diomed Developments, Blistex, EPIEN Medical, Henry Schein, Meda Pharmaceuticals, Taro Pharmaceuticals Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Mouth Ulcer Market Report Segments:
The global Drugs for Mouth Ulcer market is segmented on the basis of:
Types
Antihistamine, Antibacterial, Corticosteroid and Analgesic, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Blistex
- Church & Dwight
- Novartis Pharmaceuticals
- Bausch Health
- Pfizer
- M
- Colgate-Palmolive
- Sinclair Pharma
- Blairex Laboratories
- Diomed Developments
- Blistex
- EPIEN Medical
- Henry Schein
- Meda Pharmaceuticals
- Taro Pharmaceuticals Industries
Highlights of The Drugs for Mouth Ulcer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamine
- Antibacterial
- Corticosteroid and Analgesic
- Other
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Mouth Ulcer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drugs for mouth ulcer are medications that help to heal and prevent ulcers from forming. These drugs can be prescribed by a doctor, or they may be available over the counter (OTC). Some of the most common drugs used to treat mouth ulcers include ibuprofen, naproxen, and aspirin.
Some of the major companies in the drugs for mouth ulcer market are Blistex, Church & Dwight, Novartis Pharmaceuticals, Bausch Health, Pfizer, M, Colgate-Palmolive, Sinclair Pharma, Blairex Laboratories, Diomed Developments, Blistex, EPIEN Medical, Henry Schein, Meda Pharmaceuticals, Taro Pharmaceuticals Industries.
The drugs for mouth ulcer market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs for Mouth Ulcer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drugs for Mouth Ulcer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drugs for Mouth Ulcer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drugs for Mouth Ulcer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drugs for Mouth Ulcer Market Size & Forecast, 2020-2028
4.5.1 Drugs for Mouth Ulcer Market Size and Y-o-Y Growth
4.5.2 Drugs for Mouth Ulcer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antihistamine
5.2.2 Antibacterial
5.2.3 Corticosteroid and Analgesic
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drugs for Mouth Ulcer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drugs for Mouth Ulcer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antihistamine
9.6.2 Antibacterial
9.6.3 Corticosteroid and Analgesic
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antihistamine
10.6.2 Antibacterial
10.6.3 Corticosteroid and Analgesic
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antihistamine
11.6.2 Antibacterial
11.6.3 Corticosteroid and Analgesic
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antihistamine
12.6.2 Antibacterial
12.6.3 Corticosteroid and Analgesic
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antihistamine
13.6.2 Antibacterial
13.6.3 Corticosteroid and Analgesic
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drugs for Mouth Ulcer Market: Competitive Dashboard
14.2 Global Drugs for Mouth Ulcer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Blistex
14.3.2 Church & Dwight
14.3.3 Novartis Pharmaceuticals
14.3.4 Bausch Health
14.3.5 Pfizer
14.3.6 M
14.3.7 Colgate-Palmolive
14.3.8 Sinclair Pharma
14.3.9 Blairex Laboratories
14.3.10 Diomed Developments
14.3.11 Blistex
14.3.12 EPIEN Medical
14.3.13 Henry Schein
14.3.14 Meda Pharmaceuticals
14.3.15 Taro Pharmaceuticals Industries
